Lixte Biotechnology Holdings Inc (LIXT) Stock Analysis

Sector: HEALTHCARE - BIOTECHNOLOGY

Exchange: NASDAQ

Key Metrics

• Price: $2.91
• Market Cap: $26.46M
• EPS: $-1.19
• 52-Week High: $6.26
• 52-Week Low: $0.64

Market Sentiment

Lixte Biotechnology Holdings Inc currently has a Bullish sentiment score of 0.41.

About Lixte Biotechnology Holdings Inc

Lixte Biotechnology Holdings, Inc. is a clinical-stage biotechnology company based in East Setauket, New York, focused on developing innovative therapies for serious diseases utilizing its proprietary biomarker technology. With a strong emphasis on precision medicine, Lixte is advancing a diverse pipeline of novel compounds aimed at addressing critical unmet needs in oncology and neurodegenerative disorders. The company's unique approach to identifying and targeting specific enzymes positions...

GNG Research provides proprietary Safety Scores, Quality Scores, Fair Value estimates, and Valuation Ratings for Lixte Biotechnology Holdings Inc and 4,500+ other companies. Learn more about GNG Pro.

Frequently Asked Questions

Does LIXT pay dividends?

Lixte Biotechnology Holdings Inc (LIXT) does not currently pay a regular dividend.

What is LIXT's market cap?

Lixte Biotechnology Holdings Inc (LIXT) has a market capitalization of $26.46M with a current stock price of $2.91.